AP NEWS

Oncology Disease & Epidemiology Overview 2018-2028: Focus on 32 Indications in the Oncology Therapy Area - ResearchAndMarkets.com

December 18, 2018

DUBLIN--(BUSINESS WIRE)--Dec 18, 2018--The “Oncology - Disease & Epidemiology Overview” report from Decision Resources Group has been added to ResearchAndMarkets.com’s offering.

This report provides a disease market overview for each indication and global epidemiology overviews for each indication.

The Oncology Disease & Epidemiology Overview report provides disease market overviews and global epidemiology overviews for 32 indications in the Oncology therapy area:

Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Chronic Myeloid Leukemia, Hodgkin’s Lymphoma, Multiple Myeloma, Myelodysplastic Syndromes, Myelofibrosis, Non-Hodgkin’s Lymphoma and Chronic Lymphocytic Leukemia, Antibody Drug Conjugates, Biomarkers in Oncology, Chimeric Antigen Receptor (CAR) T-Cell Therapy, Clinical Trial Design, High-Cost Hematological Malignancies, Immune Checkpoint Inhibitors, Oncology Clinical Trial Monitor, Supportive Care in Oncology, Therapeutic Vaccines and Viral Therapy, Bladder Cancer, Breast Cancer, Colorectal Cancer, Gastroesophageal Cancer, Glioma, Hepatocellular Carcinoma, Malignant Melanoma, Non-Small-Cell Lung Cancer, Ovarian Cancer, Pancreatic Cancer, Prostate Cancer, Renal Cell Carcinoma, Small Cell Lung Cancer, Squamous Cell Carcinoma of the Head and Neck and Thyroid Carcinoma Disease.

The disease market overviews include information such as market size forecasts, prevailing treatment trend analysis and predictions, key areas of unmet need, current and emerging therapies, physician (KOL) insights, clinical pipeline analysis, and more, for each indication.

The global epidemiology overviews provide insights including global diagnosed prevalence, diagnosed prevalence by region, 10-year diagnosed prevalence growth forecast, relative sizes of the factors contributing to the trend in prevalent cases, and more, for each indication.

Key Topics Covered:

About the Analyst About the analyst’s Epidemiology Disease Landscape and Insight Overview Epidemiology Overview

Companies Mentioned

Merck & Co. Bristol Myers-Squibb Novartis Incyte CTI Biopharma Bioscience

For more information about this report visit https://www.researchandmarkets.com/research/8t474l/oncology_disease?w=4

View source version on businesswire.com:https://www.businesswire.com/news/home/20181218005295/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Related Topics:Oncology

KEYWORD:

INDUSTRY KEYWORD: HEALTH ONCOLOGY

SOURCE: Research and Markets

Copyright Business Wire 2018.

PUB: 12/18/2018 03:56 AM/DISC: 12/18/2018 03:55 AM

http://www.businesswire.com/news/home/20181218005295/en

AP RADIO
Update hourly